NR1I2 and obesity due to melanocortin 4 receptor deficiency: Furthermore, TBC treatment increased the thickness of mucus layer in HFD-induced mice (Fig. 6i) but failed to elevate the thickness of mucus layer in PXR−/− mice (Figure S7e), which may help explain why TBC administration alleviates obesity and insulin resistance.